Neutralizing Antibodies against SARS-CoV-2 and HLA Class I and II Polymorphism
Transfus Med Hemother
.
2021 May;48(3):173-174.
doi: 10.1159/000515149.
Epub 2021 Mar 11.
Authors
Lisa Weidner
1
,
Julia Kalser
1
,
Thomas R Kreil
2
,
Christof Jungbauer
1
,
Wolfgang R Mayr
1
Affiliations
1
Austrian Red Cross, Blood service for Vienna, Lower Austria and Burgenland, Vienna, Austria.
2
Global Pathogen Safety, Baxter AG, a Takeda company, Vienna, Austria.
PMID:
34177422
PMCID:
PMC8018198
DOI:
10.1159/000515149
No abstract available